SAMY METYAS: Open Payments
NPI 1831104694 · COVINA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230,023 in 441 payments from 30 companies in 2025. Trend: 2023 $225,955 · 2024 $220,041 · 2025 $230,023
Speaker / faculty: $169,382Travel & lodging: $23,637Honoraria: $15,750Consulting: $10,965Food & beverage: $10,068Education: $221
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 116 | $57,602 |
| Mallinckrodt Hospital Products Inc. | 36 | $34,699 |
| ABBVIE INC. | 50 | $31,208 |
| Lilly USA, LLC | 25 | $22,664 |
| ANI Pharmaceuticals, Inc. | 29 | $18,657 |
| UCB, Inc. | 50 | $17,014 |
| Janssen Biotech, Inc. | 28 | $16,987 |
| GENZYME CORPORATION | 11 | $12,287 |
| KYOWA KIRIN, INC. | 12 | $7,097 |
| Novartis Pharmaceuticals Corporation | 17 | $5,163 |
Products named: ACTHAR, KRYSTEXXA, RINVOQ, PURIFIED CORTROPHIN GEL, Bimzelx, TREMFYA, UPLIZNA, KEVZARA.
Industry payments across CA — which companies pay providers there.
